Mars' CocoaVia cuts LDL cholesterol 6%

13 November 2006

New data published in the November issue of the Journal of the American Dietetic Association suggests that supplementing diet with sterol-enriched chocolate bars could promote cardiovascular health. Researchers at the USA's University of California-Davis found that including CocoaVia snack bars as part of a healthy diet helped to significantly lower both total and low-density lipoprotein cholesterol levels, without cutting high-density lipoprotein cholesterol.

The researchers studied 67 men and women with elevated cholesterol (>200mg/dL total cholesterol) who were randomly assigned to one of two groups. One cohort was instructed to consume the CocoaVia snack bar twice daily, while another group was told to consume a placebo product for the full six weeks.

At the end of study period, total cholesterol levels had decreased 4.7% on average, while LDL levels, had fallen 6% in the group who regularly consumed the CocoaVia snack bar formulated with plant sterols. Those who consumed the placebo did not experience any significant reduction in either total or LDL cholesterol levels.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight